Estetrol - 97%, high purity , Estrogen receptor agonist, CAS No.15183-37-6, Estrogen receptor agonist

Item Number
E336724
Grouped product items
SKUSizeAvailabilityPrice Qty
E336724-1mg
1mg
In stock
$157.90
E336724-5mg
5mg
In stock
$711.90
E336724-10mg
10mg
In stock
$1,279.90
E336724-25mg
25mg
In stock
$2,879.90
E336724-50mg
50mg
In stock
$5,183.90

a metabolite of Estradiol

Basic Description

Synonymsestra-1,3,5(10)-triene-3,15alpha,16alpha,17beta-tetrol | Drovelis (EMA); ; estetrol monohydrate + drospirenone | ESTETROL [WHO-DD] | (14beta,15alpha,16alpha,17alpha)-Estra-1,3,5(10)-Triene-3,15,16,17-Tetrol | GTPL11591 | WHO 10439 | AT27982 | CHEBI:14277
Specifications & PurityMoligand™, ≥97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionEstrogen receptor agonist
Product Description

A metabolite of Estradiol that is an estrogenic steroid synthesized exclusively by the fetal liver during human pregnancy and reaches the maternal circulation through the placenta.

Product Properties

ALogP1.5

Associated Targets(Human)

ESR1 Tclin Estrogen receptor (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ESR2 Tclin Estrogen receptor beta (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name (8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol
INCHI InChI=1S/C18H24O4/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3/t12-,13-,14-,15-,16-,17+,18+/m1/s1
InChi Key AJIPIJNNOJSSQC-NYLIRDPKSA-N
Canonical SMILES CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O
Isomeric SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O
PubChem CID 27125
Molecular Weight 304.38

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
L2214663Certificate of AnalysisDec 08, 2022 E336724
L2214965Certificate of AnalysisDec 08, 2022 E336724
L2215307Certificate of AnalysisDec 08, 2022 E336724
L2215308Certificate of AnalysisDec 08, 2022 E336724
L2215312Certificate of AnalysisDec 08, 2022 E336724

Chemical and Physical Properties

SolubilitySoluble in methanol, and acetone.
Refractive Indexn20D1.65 (Predicted)
Boil Point(°C)491.94° C at 760 mmHg (Predicted)
Melt Point(°C)233-236° C

Safety and Hazards(GHS)

Pictogram(s) GHS08
Signal Danger
Hazard Statements

H351:Suspected of causing cancer

H360:May damage fertility or the unborn child

H362:May cause harm to breast-fed children

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P270:Do not eat, drink or smoke when using this product.

P263:Avoid contact during pregnancy/while nursing.

P203:Obtain, read and follow all safety instructions before use.

P318:if exposed or concerned, get medical advice.

Related Documents

References

1. Coelingh Bennink HJ, Holinka CF, Diczfalusy E.  (2008)  Estetrol review: profile and potential clinical applications..  Climacteric,  11 Suppl 1  (13): (47-58).  [PMID:18464023] [10.1021/op500134e]
2. Visser M, Foidart JM, Coelingh Bennink HJ.  (2008)  In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism..  Climacteric,  11 Suppl 1  (13): (64-8).  [PMID:18464025] [10.1021/op500134e]
3. P K.  (2021)  Estetrol and the possibilities of its clinical use..  Ceska Gynekol,  86  (3): (217-221).  [PMID:34167315] [10.1021/op500134e]

Solution Calculators